COLL

Collegium Pharmaceutical Inc. Common Stock (COLL)

Stock · NASDAQ · Health Care

$25.35as of 8/28/2026

Active signals

No technical signal is currently active for this symbol.

Resistance level
$34.47
Industry
Biotechnology: Pharmaceutical Preparations

How Collegium Pharmaceutical Inc. Common Stock Makes Money

Where the revenue actually goes — FY2025 annual results

market-wall.comTotalRevenue$780.57MNet Income$62.87M (8%)Cost of Revenue$317.31M (41%)SG&A$284.80M (36%)Other$85.83M (11%)Tax$29.75M (4%)COLL

Source: 10-K filed Feb 26, 2026 · via SEC EDGAR / Finnhub

Collegium Pharmaceutical Inc. Common Stock Competitors

Chosen by industry and closest market cap.

  • COLL
    Collegium Pharmaceutical Inc. Common Stock
    $25.31
    ▼ 4.27%
    Market cap $1.15BP/E
  • SDGR
    Schrodinger Inc. Common Stock
    $19.7
    ▼ 3.48%
    Market cap $1.14BP/E
    $10.95$23.02
  • CRVS
    Corvus Pharmaceuticals Inc. Common Stock
    $14.15
    ▼ 3.87%
    Market cap $1.12BP/E
    $5.28$26.95
  • MNKD
    MannKind Corporation Common Stock
    $3.96
    ▼ 2.59%
    Market cap $1.21BP/E
    $2.23$6.51
  • SVRA
    Savara Inc. Common Stock
    $5.27
    ▼ 4.10%
    Market cap $1.09BP/E
    $3.19$7.01
  • LBRX
    LB Pharmaceuticals Inc Common Stock
    $47.8
    ▼ 0.20%
    Market cap $1.23BP/E
    $13.36$50.16
  • ARDX
    Ardelyx Inc. Common Stock
    $3.81
    ▼ 0.26%
    Market cap $1.23BP/E
    $3.73$8.4

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held
36.63M
Total value held
$1.19B
Institutional holders
258
Top holders this quarter
  • Unknown5.13M
  • Unknown1.83M
  • Unknown1.59M
  • Unknown1.50M
  • Unknown1.47M
  • Unknown1.42M
  • Unknown1.42M
  • Unknown1.37M
  • Unknown1.33M
  • Unknown1.30M

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.